AMT-151 in Patients With Selected Advanced Solid Tumours
NCT 05498597 Brief Summary This first-in-human study will evaluate the Maximum Tolerated…
Read more arrow_forwardNCT 05498597 Brief Summary This first-in-human study will evaluate the Maximum Tolerated…
Read more arrow_forwardNCT 05906862 Brief Summary This first-in-human study will evaluate the Maximum Tolerated…
Read more arrow_forwardACTRN 12620000583943 Brief Summary The purpose of this study is to examine…
Read more arrow_forwardACTRN 12622001189718 Brief Summary The purpose of this study is to assess…
Read more arrow_forwardNCT 03897881 Brief Summary The purpose of this study is to assess…
Read more arrow_forwardNCT 07206056 Brief Summary This is a two-part, Phase I/II, open-label, global,…
Read more arrow_forwardNCT 03340129 Brief Summary This is a phase II, open label, randomised…
Read more arrow_forwardNCT 03175224 Brief Summary To assess: efficacy of APL-101 as monotherapy for…
Read more arrow_forwardNCT 05807035 Brief Summary Phase 1 trial to evaluate the feasibility of…
Read more arrow_forwardNCT 06106945 Brief Summary This is a Phase I/II, modular, open-label, multicenter,…
Read more arrow_forward